MENAFN

(MENAFN) Guinea-Bissau has terminated a contentious hepatitis B vaccine trial bankrolled by the Trump administration following a sharp ethical rebuke from the World Health Organization (WHO), which warned the study risked causing irreversible harm...

MENAFN

(MENAFN) Guinea-Bissau has terminated a controversial hepatitis B vaccine study financed by the administration of US President Donald Trump after the World Health Organization raised ethical concerns about the project’s design.

EIN Presswire

On-the-ground investigation raised alarms about safeguards for children, conflicts of interest, and grant oversight.

EIN Presswire

Following WHO’s statement of concern, Stand Up For Science urges immediate action to halt unethical research practices.

GlobeNewswire, Inc.

HOUSTON, April 29, 2026 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (the “Company” or “Itafos”) today reported its Q1 2026 financial results and provided a corporate update.

GlobeNewswire, Inc.

HOUSTON, April 17, 2026 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (“Itafos” or “the Company”) today announces that its financial results for Q1 2026 will be released after market close on Wednesday, April 29, 2026. An on-demand...